Back to search
High Risk Proliferative Diabetic Retinopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Proliferative Diabetic Retinopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Proliferative Diabetic Retinopathy trials you may qualify forPatients with diabetic macular edema (DME) sometimes must undergo vitrectomy surgery (PPV) for diabetic and non-diabetic related issues. Patients may have impro…
Patients undergoing surgery for complications related to diabetes will be recruited.
The purpose of this Phase 4 study is to evaluate the safety of aflibercept 8mg in patients with proliferative diabetic retinopathy without center-involved diabe…
Proliferative diabetic retinopathy is a vision-threatening disease that can lead to irreversible visual loss. The treatment options for proliferative diabetic r…
Subjects receiving 16% C3F8 gas tamponade during vitrectomy will have better visual acuity and similar postoperative complications to subjects who receive silic…